However, while Nrf2 modulation by diet is supported by preclinical and limited clinical evidence, targeting G-quadruplexes as a strategy to counteract oxidative stress in MS remains largely speculative and requires further investigation. This evidence concerns the gene NFE2L2 and myeloid sarcoma.